Symrise flags profit decline, missed growth targets, and EU probes
Symrise reported profit declines after end-2025 write-downs, missed organic growth and new product targets, and is selling its U.S. terpene unit AmeriTerpenes to Mutares with supply deals intact. EU antitrust probes continue.